Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety Study to Evaluate the Sensing and Stimulation Performance of a Personalised Sacral Neuromodulation (SNM) System for Refractory Overactive Bladder

NCT07193407 is registered in ClinicalTrials.gov with INOPASE Pty Ltd as lead sponsor.

NCT NCT07193407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety Study to Evaluate the Sensing and Stimulation Performance of a Personalised Sacral Neuromodulation (SNM) System for Refractory Overactive Bladder
Lead sponsor
INOPASE Pty Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
February 27, 2026
Completion date
December 31, 2026
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder (oab)